1. 2610 Combination of bleomycin, etoposide and cisplatin (BEP) versus etoposide and cisplatin (EP) in patients with good risk nonseminomatous germ cell tumors (NSGCT). (September 2015) Authors: Tryakin, A.; Fedyanin, M.; Bulanov, A.; Titov, D.; Mitin, A.; Sergeev, J.; Figurin, K.; Fainstein, I.; Matveev, V.; Zakharova, T.; Kostjakova, L.; Garin, A.; Tjulandin, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2611 Treatment efficacy and prognostic factors in patients (pts) with metastatic nongerm cell tumors of testis. (September 2015) Authors: Fedyanin, M.; Tryakin, A.; Bulanov, A.; Sekhina, O.; Sergeev, Y.; Fainshtein, I.; Tjulandin, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P-049A population study of correlation between the treatment rate for monoclonal antibodies (Mabs) and mortality rate in patients with metastatic colorectal cancer (mCRC) in Russia. (21st June 2016) Authors: Fedyanin, M.; Polyanskaya, E.; Sekhina, O.; Tryakin, A.; Tjulandin, S. Journal: Annals of oncology Issue: Volume 27(2016)Supplement 2 Page Start: ii15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗